Sarepta Therapeutics · 3 days ago
Associate II, Quality Control
Wonder how qualified you are to the job?
BiotechnologyGenetics
Insider Connection @Sarepta Therapeutics
Responsibilities
Perform routine and non-routine analytical tests of custom raw material per cGMP for release and stability samples using HPLC, GC, KF, and other general laboratory techniques.
Review raw data, protocols, reports, and CoA/CoTs for release and stability of RNA based products and AAV based gene therapy products generated internally and at vendor sites.
Create and maintain clear and concise lab records and documentation.
Monitor, review, and trend stability data.
Assist in writing and reviewing quality documents such as test methods, SOP, change controls, and investigations originated internally and at vendor sites.
Support method transfer and qualification/validation activities associated with the release of raw materials for RNA and AAV platforms.
Perform other related duties incidental to the work described.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
MS with 1-2 years or BS with 2-4 years in Chemistry or related science field
Experience in general laboratory organization, experimental design, and documentation (GDP) with adherence to cGMP
Must have attention to details and strong organizational skills
Must have effective written and verbal communication skills
Operate as part of a team, assisting associates in providing a functional, safe working environment while maximizing laboratory efficiency
This position requires work on site at one of Sarepta’s facilities in the United States
Candidates must be authorized to work in the U.S.
Preferred
Experience with laboratory equipment operation namely HPLC, GC, KF, pH, qPCR, ELISA, SDS-PAGE, Sanger sequencing, UV spectrophotometry is desired
Benefits
Competitive compensation and benefit package
Company
Sarepta Therapeutics
Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.
Funding
Current Stage
Public CompanyTotal Funding
$1.39BKey Investors
Michael Andrew ChambersPharmakon AdvisorsMidCap Financial
2022-09-14Post Ipo Equity· $5.96M
2021-10-13Post Ipo Equity· $500M
2020-02-14Post Ipo Equity· $400M
Recent News
2024-06-04
Investor's Business Daily
2024-06-04
2024-06-04
Company data provided by crunchbase